PHILADELPHIA, Nov. 18, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB - News) announced it has entered a contract, valued at more than $1 Million, with Lovelace Respiratory Research Institute (LRRI), Albuquerque, N.M. LRRI is the nation’s largest independent, not-for-profit organization conducting basic and applied research on the causes and treatment of respiratory illness and disease. LRRI research includes preclinical studies of new pharmaceuticals including Ampligen(r), an experimental therapeutic.
